My bookmarksSign up free
Source

Commission Implementing Regulation (EU) 2016/950 of 15 June 2016 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2,4-DB, beta-cyfluthrin, carfentrazone ethyl, Coniothyrium minitans Strain CON/M/91-08 (DSM 9660), cyazofamid, deltamethrin, dimethenamid-P, ethofumesate, fenamidone, flufenacet, flurtamone, foramsulfuron, fosthiazate, imazamox, iodosulfuron, iprodione, isoxaflutole, linuron, maleic hydrazide, mesotrione, oxasulfuron, pendimethalin, picoxystrobin, silthiofam and trifloxystrobin (Text with EEA relevance)

Commission Implementing Regulation (EU) 2016/950 of 15 June 2016 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2,4-DB, beta-cyfluthrin, carfentrazone ethyl, Coniothyrium minitans Strain CON/M/91-08 (DSM 9660), cyazofamid, deltamethrin, dimethenamid-P, ethofumesate, fenamidone, flufenacet, flurtamone, foramsulfuron, fosthiazate, imazamox, iodosulfuron, iprodione, isoxaflutole, linuron, maleic hydrazide, mesotrione, oxasulfuron, pendimethalin, picoxystrobin, silthiofam and trifloxystrobin (Text with EEA relevance)

Implementing Regulation (EU) 2016/950 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

Article 2

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (1) in the sixth column, expiration of approval, of row 29, Ethofumesate, the date is replaced by ‘31 July 2017’; (2) in the sixth column, expiration of approval, of row 40, Deltamethrin, the date is replaced by ‘31 October 2017’; (3) in the sixth column, expiration of approval, of row 41, Imazamox, the date is replaced by ‘31 July 2017’; (4) in the sixth column, expiration of approval, of row 42, Oxasulfuron, the date is replaced by ‘31 July 2017’; (5) in the sixth column, expiration of approval, of row 44, Foramsulfuron, the date is replaced by ‘31 July 2017’; (6) in the sixth column, expiration of approval, of row 46, Cyazofamid, the date is replaced by ‘31 July 2017’; (7) in the sixth column, expiration of approval, of row 47, 2,4-DB, the date is replaced by ‘31 October 2017’; (8) in the sixth column, expiration of approval, of row 48, Beta-cyfluthrin, the date is replaced by ‘31 October 2017’; (9) in the sixth column, expiration of approval, of row 50, Iprodione, the date is replaced by ‘31 October 2017’; (10) in the sixth column, expiration of approval, of row 51, Linuron, the date is replaced by ‘31 July 2017’; (11) in the sixth column, expiration of approval, of row 52, Maleic hydrazide, the date is replaced by ‘31 October 2017’; (12) in the sixth column, expiration of approval, of row 53, Pendimethalin, the date is replaced by ‘31 July 2017’; (13) in the sixth column, expiration of approval, of row 59, Trifloxystrobin, the date is replaced by ‘31 July 2017’; (14) in the sixth column, expiration of approval, of row 60, Carfentrazone ethyl, the date is replaced by ‘31 July 2017’; (15) in the sixth column, expiration of approval, of row 61, Mesotrione, the date is replaced by ‘31 July 2017’; (16) in the sixth column, expiration of approval, of row 62, Fenamidone, the date is replaced by ‘31 July 2017’; (17) in the sixth column, expiration of approval, of row 63, Isoxaflutole, the date is replaced by ‘31 July 2017’; (18) in the sixth column, expiration of approval, of row 64, Flurtamone, the date is replaced by ‘31 October 2017’; (19) in the sixth column, expiration of approval, of row 65, Flufenacet, the date is replaced by ‘31 October 2017’; (20) in the sixth column, expiration of approval, of row 66, Iodosulfuron, the date is replaced by ‘31 October 2017’; (21) in the sixth column, expiration of approval, of row 67, Dimethenamid-P, the date is replaced by ‘31 October 2017’; (22) in the sixth column, expiration of approval, of row 68, Picoxystrobin, the date is replaced by ‘31 October 2017’; (23) in the sixth column, expiration of approval, of row 69, Fosthiazate, the date is replaced by ‘31 October 2017’; (24) in the sixth column, expiration of approval, of row 70, Silthiofam, the date is replaced by ‘31 October 2017’; (25) in the sixth column, expiration of approval, of row 71, Coniothyrium minitans Strain CON/M/91-08 (DSM 9660), the date is replaced by ‘31 October 2017’.

Other acts of the same type
Commission Implementing Regulation (EU) 2018/1799 of 21 November 2018 on the establishment of a temporary direct statistical action for the dissemination of selected topics of the 2021 population and housing census geocoded to a 1 km2 grid (Text with EEA relevance.)Regulation (EU) 2018/1845 of the European Central Bank of 21 November 2018 on the exercise of the discretion under Article 178(2)(d) of Regulation (EU) No 575/2013 in relation to the threshold for assessing the materiality of credit obligations past due (ECB/2018/26)Commission Implementing Regulation (EU) 2018/1851 of 21 November 2018 entering a name in the register of protected designations of origin and protected geographical indications (‘Bayrisch Blockmalz’/‘Bayrischer Blockmalz’/‘Echt Bayrisch Blockmalz’/‘Aecht Bayrischer Blockmalz’ (PGI))Commission Regulation (EU) 2018/1793 of 20 November 2018 approving amendments to the technical file of a geographical indication for a spirit drink listed in Annex III to Regulation (EC) No 110/2008 resulting in changes to its main specifications (‘Ron de Guatemala’ (GI))Commission Implementing Regulation (EU) 2018/1795 of 20 November 2018 laying down procedure and criteria for the application of the economic equilibrium test pursuant to Article 11 of Directive 2012/34/EU of the European Parliament and of the Council (Text with EEA relevance.)Commission Implementing Regulation (EU) 2018/1796 of 20 November 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, bifenox, chlorpyrifos, chlorpyrifos-methyl, clofentezine, dicamba, difenoconazole, diflubenzuron, diflufenican, dimoxystrobin, fenoxaprop-p, fenpropidin, lenacil, mancozeb, mecoprop-p, metiram, nicosulfuron, oxamyl, picloram, pyraclostrobin, pyriproxyfen and tritosulfuron (Text with EEA relevance.)Commission Implementing Regulation (EU) 2018/2032 of 20 November 2018 amending Commission Regulation (EC) No 416/2007 concerning the technical specifications for Notices to SkippersCommission Implementing Regulation (EU) 2018/1786 of 19 November 2018 approving an amendment to the specification for a Protected Designation of Origin or a Protected Geographical Indication (‘Chianti Classico’ (PDO))Commission Implementing Regulation (EU) 2018/1781 of 16 November 2018 amending Council Regulation (EC) No 1210/2003 concerning certain specific restrictions on economic and financial relations with IraqCommission Implementing Regulation (EU) 2018/1785 of 15 November 2018 concerning the classification of certain goods in the Combined NomenclatureRegulation (EU) 2018/1717 of the European Parliament and of the Council of 14 November 2018 amending Regulation (EU) No 1093/2010 as regards the location of the seat of the European Banking Authority (Text with EEA relevance)Regulation (EU) 2018/1718 of the European Parliament and of the Council of 14 November 2018 amending Regulation (EC) No 726/2004 as regards the location of the seat of the European Medicines Agency (Text with EEA relevance)

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next